Avadel Pharmaceuticals PLC (NASDAQ:AVDL)
| 6.77 Delayed Data As of 3:59pm ET |  -0.04 / -0.59%Today’s Change | 1.05 Today|||52-Week Range 11.59 | -16.21% Year-to-Date |
Latest AVDL News | Press Releases
| Wall Street Analysts Think Avadel (AVDL) Could Surge 106%: Read This Before Placing a Bet Aug 05 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 6.81 |
| Today’s open | 6.61 |
| Day’s range | 6.44 - 6.79 |
| Volume | 13,449 |
| Average volume (3 months) | 3,093,560 |
| Market cap | $414.4M |
Data as of 3:59pm ET, 08/18/2022
Growth & Valuation
| Earnings growth (last year) | -1,096.30% |
| Earnings growth (this year) | -30.72% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 5.24 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Tempo Scan Pacific T... | 0.00 | 0.00% |
| OCULOcular Therapeutix I... | +0.08 | +1.52% |
| ---- | ||
| EIGREiger BioPharmaceuti... | -0.12 | -1.28% |
Data as of 4:00pm ET, 08/18/2022
Financials
| Next reporting date | November 7, 2022 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$77.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
